Redox-sensitive inflammatory mediators

Redox-sensitive inflammatory mediators represent a broad class of molecules, including transcription factors like Nuclear Factor-kappa B (NF-κB) and Activator Protein-1 (AP-1), whose activity is modulated by the cellular reduction-oxidation (redox) state (Gloire et al., 2006 [PMID: 16677071]). These mediators are typically activated by reactive oxygen species (ROS) and reactive nitrogen species (RNS), which act as secondary messengers to trigger the expression of pro-inflammatory genes, including cytokines, chemokines, and enzymes like COX-2 (Morgan & Liu, 2011 [PMID: 21233324]). While this process is essential for normal host defense and cellular signaling, chronic oxidative stress leads to the persistent activation of these mediators, driving the pathogenesis of inflammatory diseases such as atherosclerosis, rheumatoid arthritis, and neurodegeneration (Reuter et al., 2010 [PMID: 21113969]). Therapeutic intervention often involves the use of antioxidants to scavenge ROS or specific inhibitors to block the activation of redox-sensitive signaling cascades. However, because redox signaling is also vital for physiological homeostasis, broad-spectrum inhibition poses significant challenges regarding specificity and safety. Biotech development in this area increasingly focuses on precision targeting of specific redox-sensitive nodes to minimize off-target effects on essential cellular processes.

Other names

Redox-regulated inflammatory factorsROS-sensitive inflammatory signaling moleculesRedox-sensitive transcription factors and cytokines

Modulation of cellular redox state through the scavenging of reactive oxygen species (ROS) or the direct inhibition of redox-sensitive signaling components such as the IKK complex in the NF-κB pathway (Gloire et al., 2006 [PMID: 16677071]).